{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:52:35Z","timestamp":1791924755506,"version":"4.3.4"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:00:00Z","timestamp":1654128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Guillain\u2013Barr\u00e9 syndrome(GBS) is an autoimmune-mediated peripheral neuropathy. Immune checkpoint inhibitors (ICIs) are the standard treatment for cancer and may lead to immune-related adverse events (irAEs) such as GBS. Corticosteroids, plasma exchange (PE), and intravenous immunoglobulin (IVIG) are currently accepted treatments for ICI-induced GBS. However, there are still adverse reactions, and the effect of relieving symptoms is not as good as expected. Safe and effective complementary replacement therapy to alleviate GBS symptoms and ameliorate the quality of life is urgently required. In this case, a 63-year-old man received ICI therapy and antitumor chemotherapy for lung malignancy. After two courses of treatment, the patient gradually developed limb weakness, numbness, and pain at the ends of the limbs, with cerebrospinal fluid (CSF) albuminocytological dissociation, and electromyography (EMG) suggested demyelinating changes and was diagnosed as GBS. Although the patient received high doses of intravenous gamma globulin and limb weakness symptoms were alleviated, there was still significant numbness and pain in the extremities. After four times of acupuncture treatments, the patient complained that the symptoms of limb numbness and fatigue were significantly alleviated without any discomfort. This case report may provide a new alternative and complementary therapy for immune checkpoint inhibitor-induced GBS, but more definitive and robust evidence is needed to support its efficacy.<\/jats:p>","DOI":"10.3389\/fneur.2022.908282","type":"journal-article","created":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T09:40:10Z","timestamp":1654162810000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Acupuncture Treatment of Guillain\u2013Barr\u00e9 Syndrome After Using Immune Checkpoint Inhibitors: A Case Report"],"prefix":"10.3389","volume":"13","author":[{"given":"Jialing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danghan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muxi","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1212\/CON.0000000000000513","article-title":"Guillain-Barr\u00e9 Syndrome","volume":"23","author":"Donofrio","year":"2017","journal-title":"Continuum (Minneap Minn)."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/S0140-6736(21)00517-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"397","author":"Shahrizaila","year":"2021","journal-title":"Lancet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"388","author":"Willison","year":"2016","journal-title":"Lancet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000324710","article-title":"Population incidence of Guillain-Barr\u00e9 syndrome: a systematic review and meta-analysis","volume":"36","author":"Sejvar","year":"2011","journal-title":"Neuroepidemiology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000184748","article-title":"The epidemiology of Guillain-Barr\u00e9 syndrome worldwide. A systematic literature review","volume":"32","author":"McGrogan","year":"2009","journal-title":"Neuroepidemiology."},{"key":"B6","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/1759-7714.13240","article-title":"Clinical diagnosis and treatment of immune checkpoint inhibitor-associated pneumonitis","volume":"11","author":"Wang","year":"2020","journal-title":"Thorac Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejca.2016.12.001","article-title":"Neurological adverse events associated with immune checkpoint inhibitors: review of the literature","volume":"73","author":"Cuzzubbo","year":"2017","journal-title":"Eur J Cancer."},{"key":"B8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1200\/JCO.2018.36.5_suppl.37","article-title":"Myasthenia gravis and Guillain-Barr\u00e9 syndrome adverse events with immune checkpoint inhibitors","volume":"36","author":"Garcia","year":"2018","journal-title":"J Clin Oncol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"9800488","DOI":"10.1155\/2021\/9800488","article-title":"Guillain-Barr\u00e9 syndrome-like polyneuropathy associated with immune checkpoint inhibitors: a systematic review of 33 cases","volume":"2021","author":"Li","year":"2021","journal-title":"Biomed Res Int"},{"key":"B10","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1007\/s00415-020-10213-x","article-title":"Polyradiculoneuropathy induced by immune checkpoint inhibitors: a case series and review of the literature","volume":"268","author":"Okada","year":"2021","journal-title":"J Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/jns5.12051","article-title":"Health-related quality of life in Guillain-Barr\u00e9 syndrome patients: a systematic review","volume":"19","author":"Darweesh","year":"2014","journal-title":"J Peripher Nerv Syst."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1212\/WNL.0b013e3181f88345","article-title":"van Doorn PA, Dutch GBS Study Group. Pain in Guillain-Barre syndrome: a long-term follow-up study","volume":"75","author":"Ruts","year":"2010","journal-title":"Neurology."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.3390\/ijms18112270","article-title":"Mechanisms of acupuncture therapy in ischemic stroke rehabilitation: a literature review of basic studies","volume":"18","author":"Chavez","year":"2017","journal-title":"Int J Mol Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.2147\/CIA.S210751","article-title":"Cardioprotective effect of transcutaneous electrical acupuncture point stimulation on perioperative elderly patients with coronary heart disease: a prospective, randomized, controlled clinical trial","volume":"14","author":"Li","year":"2019","journal-title":"Clin Interv Aging."},{"key":"B15","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s11916-013-0321-3","article-title":"Acupuncture for cancer pain and related symptoms","volume":"17","author":"Lu","year":"2013","journal-title":"Curr Pain Headache Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","article-title":"Guillain-Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis","volume":"10","author":"van den Berg","year":"2014","journal-title":"Nat Rev Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1212\/WNL.0b013e3181e07d14","article-title":"Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study, Neurology","volume":"74","author":"Ruts","year":"2010"},{"key":"B18","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/jns.12413","article-title":"Oxaliplatin- and docetaxel-induced polyneuropathy: clinical and neurophysiological characteristics","volume":"25","author":"Bennedsgaard","year":"2020","journal-title":"J Peripher Nerv Syst"},{"key":"B19","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/WCO.0000000000000234","article-title":"Chemotherapy-induced peripheral neurotoxicity","volume":"28","author":"Cavaletti","year":"2015","journal-title":"Curr Opin Neurol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1053\/j.seminoncol.2005.12.010","article-title":"Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy","volume":"33","author":"Hausheer","year":"2006","journal-title":"Semin Oncol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/bja\/aex229","article-title":"Clinical and preclinical perspectives on Chemotherapy-Induced Peripheral Neuropathy (CIPN): a narrative review","volume":"119","author":"Flatters","year":"2017","journal-title":"Br J Anaesth."},{"key":"B22","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1212\/WNL.0b013e3181cff735","article-title":"Axonal variant of Guillain-Barre syndrome associated with Campylobacter infection in Bangladesh","volume":"74","author":"Islam","year":"2010","journal-title":"Neurology."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1093\/brain\/awy232","article-title":"Regional variation of Guillain-Barr\u00e9 syndrome","volume":"141","author":"Doets","year":"2018","journal-title":"Brain"},{"key":"B24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","article-title":"Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976\u20131977","volume":"110","author":"Schonberger","year":"1979","journal-title":"Am J Epidemiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/ana.410380214","article-title":"Acute axonal Guillain-Barr\u00e9 syndrome with IgG antibodies against motor axons following parenteral gangliosides","volume":"38","author":"Illa","year":"1995","journal-title":"Ann Neurol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/0140-6736(91)90453-V","article-title":"Motoneuron-disease-like disorder after ganglioside therapy","volume":"338","author":"Scarlato","year":"1991","journal-title":"Lancet"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1007\/s00415-020-09742-2","article-title":"Axonal variants of Guillain-Barr\u00e9 syndrome: an update","volume":"268","author":"Shang","year":"2021","journal-title":"J Neurol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain-Barr\u00e9 syndrome","volume":"366","author":"Hughes","year":"2005","journal-title":"Lancet."},{"key":"B29","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1212\/WNL.0b013e3182104407","article-title":"Early recognition of poor prognosis in Guillain-Barre syndrome","volume":"76","author":"Walgaard","year":"2011","journal-title":"Neurology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00431-006-0140-1","article-title":"Infections and vaccinations preceding childhood Guillain-Barr\u00e9 syndrome: a prospective study","volume":"165","author":"Schessl","year":"2006","journal-title":"Eur J Pediatr."},{"key":"B31","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.it.2013.05.001","article-title":"Glycolipid antigens and autoantibodies in autoimmune neuropathies","volume":"34","author":"Willison","year":"2013","journal-title":"Trends Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.clinph.2019.03.035","article-title":"Electrophysiological findings in immune checkpoint inhibitor-related peripheral neuropathy","volume":"130","author":"Chen","year":"2019","journal-title":"Clin Neurophysiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/CJI.0000000000000364","article-title":"Immune Checkpoint Inhibitor-related Guillain-Barr\u00e9 syndrome: a case series and review of the literature","volume":"44","author":"Janssen","year":"2021","journal-title":"J Immunother."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1200\/JCO.2017.77.6385","article-title":"National comprehensive cancer network. Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology Clinical Practice Guideline","volume":"36","author":"Brahmer","year":"2018","journal-title":"J Clin Oncol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"255","DOI":"10.6004\/jnccn.2020.0012","article-title":"Management of immunotherapy-related toxicities, version 1","volume":"17","author":"Thompson","year":"2019","journal-title":"J Natl Compr Canc Netw."},{"key":"B36","doi-asserted-by":"publisher","first-page":"iv264","DOI":"10.1093\/annonc\/mdx225","article-title":"Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Haanen","year":"2018","journal-title":"Ann Oncol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.mayocp.2013.06.009","article-title":"Acupuncture","volume":"88","author":"Chon","year":"2013","journal-title":"Mayo Clin Proc."},{"key":"B38","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.bbi.2020.08.015","article-title":"Acupuncture inhibits neuroinflammation and gut microbial dysbiosis in a mouse model of Parkinson's disease","volume":"89","author":"Jang","year":"2020","journal-title":"Brain Behav Immun."},{"key":"B39","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.pharmthera.2015.11.012","article-title":"Gut microbiome in health and disease: Linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases","volume":"158","author":"Ghaisas","year":"2016","journal-title":"Pharmacol Ther"},{"key":"B40","doi-asserted-by":"publisher","first-page":"10609","DOI":"10.3748\/wjg.v21.i37.10609","article-title":"Brain-gut-microbiota axis in Parkinson's disease","volume":"21","author":"Mulak","year":"2015","journal-title":"World J Gastroenterol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/nm.3479","article-title":"Dopamine mediates vagal modulation of the immune system by electroacupuncture","volume":"20","author":"Torres-Rosas","year":"2014","journal-title":"Nat Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/nn.4030","article-title":"Host microbiota constantly control maturation and function of microglia in the CNS","volume":"18","author":"Erny","year":"2015","journal-title":"Nat Neurosci"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1759842","DOI":"10.1155\/2019\/1759842","article-title":"Electroacupuncture regulates disorders of gut-brain interaction by decreasing corticotropin-releasing factor in a rat model of IBS","volume":"2019","author":"Chen","year":"2019","journal-title":"Gastroenterol Res Pract"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2504674","DOI":"10.1155\/2020\/2504674","article-title":"Effectiveness of acupuncture treatment on chemotherapy-induced peripheral neuropathy: a pilot, randomized, assessor-blinded, controlled trial","volume":"2020","author":"Iravani","year":"2020","journal-title":"Pain Res Manag"},{"key":"B45","doi-asserted-by":"publisher","first-page":"283","DOI":"10.5582\/bst.2021.01318","article-title":"The positive role of traditional Chinese medicine as an adjunctive therapy for cancer","volume":"15","author":"Zhang","year":"2021","journal-title":"Biosci Trends."},{"key":"B46","doi-asserted-by":"publisher","first-page":"624","DOI":"10.3390\/biom9100624","article-title":"Electro-acupuncture alleviates cisplatin-induced anorexia in rats by modulating ghrelin and monoamine neurotransmitters","volume":"9","author":"Baek","year":"2019","journal-title":"Biomolecules"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e18619","DOI":"10.1097\/MD.0000000000018619","article-title":"The effectiveness and safety of acupuncture therapy for Guillain-Barr\u00e9 syndrome: A systematic review and meta-analysis protocol","volume":"99","author":"Fan","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"B48","first-page":"15","article-title":"The treatment of chronic inflammatory demyelinating polyradiculoneuropathy with acupuncture: a clinical case study","volume":"27","author":"Elgert","year":"1999","journal-title":"Am J Acupunct."},{"key":"B49","doi-asserted-by":"publisher","first-page":"e067475","DOI":"10.1136\/bmj-2021-067475","article-title":"Evidence on acupuncture therapies is underused in clinical practice and health policy","volume":"376","author":"Lu","year":"2022","journal-title":"BMJ."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.908282\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T09:40:13Z","timestamp":1654162813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.908282\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,2]]},"references-count":49,"alternative-id":["10.3389\/fneur.2022.908282"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.908282","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,2]]},"article-number":"908282"}}